Alexandria Real Estate Equities, Inc
Alexandria Real Estate Equities, Inc. is a Maryland corporation formed in 1994 that has elected REIT tax status and focuses on life science real estate. The company owns, operates, and develops Class A/A+ laboratory and office properties clustered into collaborative “Megacampus™” ecosystems located in major U.S. life science innovation hubs. Its business model combines long-duration leasing (often triple-net with contractual escalations) with a development pipeline and selective acquisitions in its cluster markets. Alexandria also provides strategic capital to life science companies through a venture capital platform, creating an additional (and more volatile) source of returns alongside rental income.
Fiscal year 2025 · change from previous year
Development 2020–2025
Business
Share of revenueBase rent and recoveries from operating life science properties, often structured as triple-net leases with escalations.
Ground-up development and repositioning of Class A/A+ life science properties within Megacampus ecosystems.
Economics from consolidated and unconsolidated real estate joint ventures and related property-level arrangements.
Strategic capital and investment returns from a venture platform focused on transformative life science companies.
Products
Reported · share of revenue- Income From Rentals97.3 %
- Other2.7 %
Source: 10-K FY2025, revenue the company reports per product line (SEC XBRL). Shares are of the lines shown and add up to 100 %.
Customers
Alexandria’s customers are tenants that need specialized, high-quality lab and office space in proximity to research talent, capital, and scientific infrastructure. The tenant roster spans multinational pharmaceutical companies, public and private biotechnology companies, life science tools/services and medical device firms, and adjacent categories such as digital health, advanced technology, and agtech. It also leases to academic and medical research institutions, U.S. government research agencies, and non-profit organizations, which can anchor demand in key clusters. Leasing is designed to be sticky: a large portion of leasing activity is generated from existing tenants, and many leases include annual escalations and triple-net structures that shift operating costs to tenants.
Lease significant lab/office footprints for R&D and collaboration; valued for credit quality and longer lease terms.
Lease flexible, expandable lab space within Megacampus ecosystems to support growth and talent recruitment.
Lease specialized facilities tied to research missions and funding cycles; can provide stable, long-term occupancy.
Lease space to access life science clusters and partners; adds diversification but can increase cyclicality.
Strategy
Alexandria’s strategy centers on owning and developing Class A/A+ life science properties within collaborative Megacampus™ ecosystems in established innovation clusters. The campus model is designed for tenant optionality and scalability, allowing tenants to expand within the ecosystem and supporting retention and repeat leasing. The company complements organic development with targeted acquisitions in cluster markets, underwriting assets based on tenant quality, infrastructure capacity, and proximity to centers of innovation. It also uses long-standing relationships across real estate and life science to source tenants and opportunities, and it deploys strategic capital through a venture platform to deepen ecosystem connectivity (while accepting higher valuation volatility).
Clustering supports tenant recruitment/retention and expansion demand within the portfolio.
New supply controlled by the company provides growth capacity and optionality for existing tenants.
Triple-net leases, escalations, and higher-credit tenants can stabilize cash flows and reduce expense volatility.
Geography
Alexandria’s portfolio is concentrated in North America and is organized around U.S. life science innovation clusters rather than broad national diversification. Key markets cited in filings include Greater Boston, the San Francisco Bay Area, San Diego, Seattle, Maryland, Research Triangle, and New York City, where the company builds clustered Megacampus ecosystems near academic and medical research institutions and transit. As of year-end 2025, the asset base included approximately 35.9 million rentable square feet (RSF) of operating properties and 3.5 million RSF under construction, reflecting a sizable development footprint in these clusters. Geographic concentration increases exposure to local supply/demand dynamics, entitlement and construction conditions, and tenant funding environments that can vary meaningfully by cluster.
Risks
Alexandria’s performance is tied to demand for life science lab space in a handful of major U.S. clusters, so oversupply, tenant downsizing, or reduced venture funding can pressure occupancy and rental rates. Tenant credit risk is meaningful despite a large investment-grade/large-cap mix, particularly for smaller biotech tenants that depend on capital markets and R&D milestones to fund operations. Development and redevelopment introduce execution risk (cost inflation, delays, permitting, and lease-up), and the company also faces ground lease renewal/default risk where applicable. In addition, the venture investment platform and other non-real estate investments can create earnings volatility through fair value changes and impairments, and policy shifts (regulatory, funding, staffing, trade) by the U.S. government can affect tenants and portfolio companies.
- U.S. government policy shifts affecting tenants and venture portfolioImpact: HighLikelihood: Medium
Changes to regulatory, funding, staffing, and trade policies can disrupt R&D budgets and operating conditions for pharma/biotech, institutions, and government-related research activity.
Exposure: Tenant demand/credit and venture portfolio valuations
- Inability to complete or profitably operate acquisitions/developmentsImpact: HighLikelihood: Medium
Returns depend on sourcing, underwriting, construction execution, and stabilizing occupancy in specialized lab assets.
Exposure: Development pipeline and acquisition program
- Tenant inability to pay rent / re-leasing riskImpact: HighLikelihood: Medium
Biotech and adjacent innovation tenants can face funding and industry-specific shocks that impair rent coverage and renewal demand.
Exposure: Rental revenue and occupancy
Accounting
Judgemental itemsAllocation of consideration (including acquisition costs) across land/buildings/intangibles affects depreciation/amortization and future disposition gains/losses.
Impact: Can materially change reported earnings profile and comparability across periods.
Impairments depend on cash flow projections and expected sales proceeds; changes in assumptions can trigger significant charges.
Impact: Material impact on GAAP net income; typically excluded from FFO per Nareit guidance.
Venture portfolio valuations are sensitive to external market conditions and company-specific performance, driving unrealized losses and impairments.
Impact: Increases earnings volatility and can obscure underlying property operating trends.
Similar listed companies
Publicly listed companies with a comparable business focus.
Brandywine Realty Trust
BDN · Real Estate Investment Trusts
Brandywine Realty Trust is a self-administered and self-managed U.S.
Acadia Realty Trust
AKR · Real Estate Investment Trusts
Acadia Realty Trust is a Maryland-formed equity REIT that owns, acquires, develops, and manages retail real estate in high-barrier-to-entry, supply-constrained U.S.
Alexander's, Inc
ALX · Real Estate Investment Trusts
Sila Realty Trust, Inc.
Real Estate Investment Trusts
American Assets Trust, Inc.
AAT · Real Estate Investment Trusts
Kilroy Realty Corporation
KRC · Real Estate Investment Trusts
Kilroy Realty Corp is a U.S.
Last updated: 24/09/2026